nab-paclitaxel plus carboplatin induction followed by nab-paclitaxel maintenance in squamous non-small cell lung cancer (NSCLC): Results from the ABOUND. sqm study

被引：0

作者：

Spigel, D. R. ^{[1
]}

Jotte, R. M. ^{[2
]}

Ponce Aix, S. ^{[3
]}

Gressot, L. ^{[4
]}

Morgensztern, D. ^{[5
]}

McCleod, M. ^{[6
]}

Socinski, M. A. ^{[7
]}

Daniel, D. ^{[8
]}

Juan-Vidal, O. ^{[9
]}

Kim, E. S. ^{[10
]}

West, H. J. ^{[11
]}

Chen, T. ^{[12
]}

Bhore, R. ^{[12
]}

Ong, T. J. ^{[12
]}

Gridelli, C. ^{[13
]}

Thomas, M. ^{[14
]}

机构：

[1] Sarah Cannon Res Inst, Nashville, TN USA

[2] Rocky Mt Canc Ctr, Med Oncol Hematol, Denver, CO USA

[3] H12O, CNIO, Unidad Invest Clin Canc Pulmon, Med Oncol, Madrid, Spain

[4] North Cypress Canc Ctr, Med Oncol, Cypress, TX USA

[5] Washington Univ, Sch Med, Med Oncol, St Louis, MO USA

[6] Florida Canc Specialists, Med Oncol, Ft Myers, FL USA

[7] Florida Hosp, Inst Canc, Med Oncol, Orlando, FL USA

[8] Tennessee Oncol, Med Oncol, Chattanooga, TN USA

[9] Hosp Univ & Politecn La Fe, Med Oncol, Valencia, Spain

[10] Atrium Hlth, Levine Canc Inst, Med Oncol, Charlotte, NC USA

[11] Swedish Canc Inst, Med Oncol, Seattle, WA USA

[12] Celgene Corp, Oncol, Summit, NJ USA

[13] SG Moscati Hosp, Med Oncol, Avellino, Italy

[14] Univ Klinikum Heidelberg, Translat Lung Res Ctr Heidelberg, German Ctr Lung Res DZL, Thoraxklin,Med Oncol,Internist Onkol Thoraxtumore, Heidelberg, Germany

来源：

ANNALS OF ONCOLOGY | 2018年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LBA64

引用

页数：2

共 50 条

[1] Nab-Paclitaxel Maintenance in Squamous Non-Small Cell Lung Cancer (NSCLC): Updated Results of the Phase III ABOUND.sqm Study
Spigel, D.
Jotte, R.
Aix, S.
Gressot, L.
Morgensztern, D.
Mccleod, M.
Socinski, M.
Daniel, D.
Juan, O.
Mileham, K.
West, H.
Page, R.
Reinmuth, N.
Knoble, J.
Tian, O.
Bhore, R.
Wolfsteiner, M.
Ong, T. Jin
Gridelli, C.
Thomas, M.
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S301 - S301
[2] nab-paclitaxel/carboplatin (nab-P/C) induction therapy in squamous (SCC) non-small cell lung cancer (NSCLC): Interim safety results from ABOUND.sqm
Gridelli, C.
McCleod, M.
Morgensztern, D.
Daniel, D. B.
Page, R.
Wehler, T.
Juan, O.
Levy, B.
Ardizzoni, A.
Berry, T.
Chen, T.
Trunova, N.
Jotte, R.
ANNALS OF ONCOLOGY, 2017, 28
[3] nab-Paclitaxel as Maintenance Therapy in Patients with Squamous Cell NSCLC (ABOUND.sqm)
Spigel, David R.
Gridelli, Cesare
Jotte, Robert
Kim, Edward S.
Ko, Amy
Ong, Teng Jin
Pirker, Robert
Thomas, Michael
Trunova, Nataliya
West, Howard
Reynolds, Craig H.
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S554 - S554
[4] nab-Paclitaxel/Carboplatin Followed By nab-Paclitaxel for NSCLC PS 2 (ABOUND.PS2)
Gajra, Ajeet
Socinski, Mark A.
Ali, Haythem
Amiri, Katayoun I.
Karim, Nagla Abdel
Kim, Eric
Matrana, Marc R.
Sanford, Alexandra
Trunova, Nataliya
Spigel, David R.
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S553 - S553
[5] nab-paclitaxel (nab-P) plus carboplatin (C) induction therapy in patients (Pts) with squamous (SCC) NSCLC: Interim safety results from the phase 3 ABOUND. sqm study
Vidal, O. J.
Daniel, D.
Johnson, M.
Knoble, J.
Chen, T.
McCleod, M.
Ong, T. J.
Trunova, N.
Kim, E.
ANNALS OF ONCOLOGY, 2016, 27
[6] Phase 2 study of bevacizumab plus carboplatin/nab-paclitaxel followed by bevacizumab plus nab-paclitaxel for non-squamous non-small cell lung cancer with malignant pleural effusion
Tamiya, Motohiro
Tamiya, Akihiro
Suzuki, Hidekazu
Taniguchi, Yoshihiko
Katayama, Kanako
Minomo, Shojiro
Nakao, Keiko
Takeuchi, Naoko
Matsuda, Yoshinobu
Naito, Yujiro
Shiroyama, Takayuki
Okamoto, Norio
Okishio, Kyoichi
Kumagai, Toru
Atagi, Shinji
Imamura, Fumio
Hirashima, Tomonori
INVESTIGATIONAL NEW DRUGS, 2021, 39 (04) : 1106 - 1112
[7] Effect of nab-paclitaxel/carboplatin (nab-P/C) induction therapy on quality of life (QoL) of patients with squamous (SCC) non-small cell lung cancer (NSCLC) (ABOUND.sqm)
Ponce Aix, S.
Villaflor, V.
Knoble, J.
Thomas, M.
von Pawel, J.
Bailey, S.
Hussein, M. A.
Razaq, M. A.
Sabbath, K.
Staib, P.
Chen, T.
Trunova, N.
Spigel, D. R.
ANNALS OF ONCOLOGY, 2017, 28
[8] Interim Results From the Phase I Study of Nivolumab plus nab-Paclitaxel plus Carboplatin in Non-Small Cell Lung Cancer (NSCLC)
Goldman, Jonathan W.
George, Ben
Gutierrez, Martin
Ko, Amy
O'Dwyer, Peter
Otterson, Gregory
Soliman, Hatem
Trunova, Nataliya
Waterhouse, David
Kelly, Karen
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1309 - S1309
[9] ABOUND.PS2 Interim Safety Results: nab-Paclitaxel/Carboplatin Followed by nab-Paclitaxel in NSCLC Patients with ECOG PS of 2
Gajra, Ajeet
Ali, Haythem
Amiri, Katayoun I.
Karim, Nagla A.
Matrana, Marc R.
Mulford, Deborah
Ong, Teng J.
Sanford, Alexandra
Santos, Edgardo S.
Socinski, Mark A.
Spigel, David R.
JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (11) : S274 - S274
[10] nab-Paclitaxel/Carboplatin Induction Therapy in Squamous (SCC) NSCLC: Interim Quality of Life (QoL) Results From ABOUND.sqm
Thomas, Michael
Page, Ray
Gressot, Laurent
Danie, Davey
Morgensztern, Daniel
Villaflor, Victoria
Aix, Santiago
Ong, Teng
Trunova, Nataliya
Spigel, David
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S906 - S906

← 1 2 3 4 5 →